Viewing Study NCT05418803


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2026-02-26 @ 11:05 AM
Study NCT ID: NCT05418803
Status: COMPLETED
Last Update Posted: 2022-06-16
First Post: 2022-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects
Sponsor: Yuhan Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module